Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury

Cytokine

Volumn 60, Issue 3, 2012, Pages 601-607

  Schilder, Louise ^a   Azam Nurmohamed, S ^a   ter Wee, Pieter M ^a   Girbes, Armand R J ^a   Beishuizen, Albertus ^a   Paauw, Nanne J ^a   Beelen, Robert H J ^a   Johan Groeneveld, A B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute kidney injury; Biocompatibility; Critically ill patients; Innate immunity; Renal replacement therapy

Indexed keywords

CELLULOSE TRIACETATE; CITRATE TRISODIUM; HEPARIN; INTERLEUKIN 6; INTERLEUKIN 8;

ACUTE KIDNEY FAILURE; ADSORPTION; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING TENDENCY; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FILTER; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY CLEARANCE; MALE; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN DETERMINATION; SURVIVAL; ULTRAFILTRATION;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CITRATES; FEMALE; HEMOFILTRATION; HEPARIN; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84867995486     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.015     Document Type: Article

References (34)

1. Uchino S., Kellum J.A., Bellomo R., Doig G.S., Morimatsu H., Morgera S., et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) investigators, acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
2. Oudemans-vanStraaten H.M., Bosman R.J., Koopmans M., van der Voort P.H., Wester J.P., van der Spoel J.I., et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009, 37:545-552.
3. Aman J., Nurmohamed S.A., Vervloet M.G., Groeneveld A.B. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study. J Crit Care 2010, 25:120-127.
4. Oudemans-van Straaten H.M., Fiaccadori E., Baldwin I. Anticoagulation for renal replacement therapy: different methods to improve safety. Contrib Nephrol 2010, 165:251-262.
5. Schouten W.E.M., Grooteman M.P.C., Schoorl M., van Houte A.J., Nubé M.J. Monocyte activation in peripheral blood and dialyser eluates: phenotypic profile and cytokine release. Nephron 2002, 91:646-653.
6. Alonso A., Lau J., Jaber B.L. Biocompatible hemodialysis membranes for acute renal failure [review]. Cochrane Database Syst Rev 2008, 23(1):CD005283.
7. El Habbal M.H., Smith L., Elliott M.J., Strobel S. Effect of heparin anticoagulation on neutrophil adhesion molecules and release of IL-8:C3 is not essential. Cardiovasc Res 1995, 30:676-681.
8. Johnson K., Aarden L., Choi Y., De Groot E., Creasey A. The pro-inflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996, 87:5051-5060.
9. Engstad C.S., Gutteberg TJ.O., Sterud B. Modulation of blood cell activation by four commonly used anticoagulants. Thromb Hemost 1997, 77:690-696.
10. Attanasio M., Gori A.M., Giusti B., Pepe G., Comeglio P., Brunelli T., et al. Cytokine gene expression in human LPS- and IFNγ-stimulated mononuclear cells is inhibited by heparin. Thromb Hemost 1998, 79:959-962.
11. Köller M., Kutscha-Lissberg F., Brom J., Weidinger G., Muhr G. Influence of low molecular weight heparin [certoparin] and unfractionated heparin on the release of cytokines from human leukocytes. Inflammation 2001, 25:331-337.
12. Heinzelmann M., Bosshart H. Heparin binds to lipopolysaccharide [LPS]-binding protein, facilitates the transfer of LPS to CD14, and enhances LPS-induced activation of peripheral blood monocytes. J Immunol 2005, 174:2280-2287.
13. Hochart H., Jenkins P.V., Preston R.J., Smith O.P., White B., O'Donnell J. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. Thromb Haemost 2008, 99:570-575.
14. 2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med 2008, 14:738-747.
15. Komoda H., Inoue T., Node K. Anti-inflammatory properties of azelnidipine, a dihydropyridine-based calcium channel blocker. Clin Exp Hypertens 2010, 32:121-128.
16. Simmons E.M., Himmelfarb J., Sezer M.T., Chertow G.M., Mehta R.L., Paganini E.P., et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65:1357-1365.
17. Himmelfarb J., Le P., Klenzak J., Freedman S., McMenamin M.E., Akizler T.A., et al. Impaired monocyte cytokine production in critically ill patients with acute renal failure. Kidney Int 2004, 66:2354-2360.
18. Peng Z., Pai P., Hong-Bao L., Rong L., Han-Min W., Chen H. The impacts of continuous veno-venous hemofiltration on plasma cytokines and monocyte human leukocyte antigen-DR expression in septic patients. Cytokine 2010, 50:186-191.
19. Bouman C.S.C., van Olden R.W., Stoutenbeek C.P. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 1998, 16:261-268.
20. Cole L., Bellomo R., Davenport P., Tipping P., Ronco C. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int J Artif Org 2004, 27:388-397.
21. Rimmelé T., Kellum J.A. Clinical review: blood purification for sepsis. Crit Care 2011, 15:205.
22. Bellomo R., Tipping P., Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Fail 1995, 17:457-466.
23. Hoffmann J.N., Hartl W., Deppisch R., Faist E., Jochum M., Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995, 48:1563-1570.
24. Sander A., Armbruster W., Sander B., Daul A.E., Lange R., Peters J. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF-α plasma concentrations. Intens Care Med 1997, 23:878-884.
25. Sanchez-Izquierdo Ropera J.A., Perz Vela J.L., Lozano Quintana M.J., Alted Lopez E., Ortuñode Solo B., Ambros Checa A. Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 1997, 30:483-488.
26. Heering P., Morgera S., Schmitz F.J., Schmitz G., Willers R., Schultheiss H.P., et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intens Care Med 1997, 23:288-296.
27. Koperna T., Vogl S.E., Pöschl G.P., Hamilton G., Röder G., Germann P. Cytokine patterns in patients who undergo hemofiltration for treatment of multiple organ failure. World J Surg 1998, 22:443-448.
28. Kellum J.A., Johnson J.P., Kramer D., Palevsky P., Brady J.J., Pinsky M.R. Diffusive vs convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26:1995-2000.
29. De Vriese A.S., Colardyn F.A., Philipp J.J., Vanholder R.C., De Sutter J.H., Lameire N.H. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10:846-853.
30. Sieberth H.-G., Kierdorf H.P. Is cytokine removal by continuous hemofiltration feasible?. Kidney Int 1999, 56(72):S79-S83.
31. Klouche K., Cavadore P., Portales P., Clot J., Canaud B., Béraud J.J. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFα and IL-6 plasma concentrations. J Nephrol 2002, 15:150-157.
32. Hirano T., Hirasawa H., Oda S., Shiga H., Nakanishi K., Matsuda K., et al. Modulation of polymorphonucelar leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltration. Blood Purif 2004, 22:188-197.
33. May L.T., Santhanam U., Sehgal P.B. On the multimeric nature of natural human interleukin-6. J Biol Chem 1991, 266:9950-9955.
34. Darbonne W.C., Rice G.C., Mohler M.A., Apple T., Hébert C.A., Valente A.J., et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991, 1362-1369.